Blog

The future of the Small Molecule market is likely to be impacted by several factors, including:In...

When partnering with a headhunting firm on finding the right candidate for an opportunity, you wi...

The CRO Market is experiencing rapid expansion across the board throughout 2023, and the trend is...

Viral-vector gene therapies use revised viruses as drug-delivery vehicles to introduce specific ...

With 2022 coming to an end, let’s explore what the Pharmaceutical and Biotech space can do to pre...

We are currently living in a period of huge scientific innovation with promises to improve human ...

Global economic downturn has been looming since the end of COVID-19 however, the Pharmaceutical m...

I have been directly managing people now for 18 months, and whilst still a young leader learning...

It is no secret that the headhunting industry has an exceptionally high turnover rate, roughly a...

One of the most common mistakes with phone interviews is underestimating them. Phone interviews ...

Mantell Associates Life Sciences division works with the Biotech, Pharmaceutical and Contract Res...

he Small Molecule CDMO team here at Mantell Associates is recognised as the 'go-to' partner with...

The Large Molecule CDMO arm of Mantell Associates covers all appointments within Contract Develo...

Mantell Associates Life Sciences division works with the Biotech, Pharmaceutical and Contract Re...

Neuroscience within the pharmaceutical and biotechnology industry has been a hugely controversia...

Unlike many other medical approaches, cell and gene therapies (CGTs) have the potential to be a o...

In the early dawn of February 24th, Russian President Vladimir Putin launched what was to become...

The clinical trial industry has always struggled with diverse recruitment within their trials. O...

Digital Transformation is developing new high tech ways or modifying existing systems to help a c...

As part of the Mantell Associates Network podcast earlier last year, CEO Alessandro Mantell w...

Insights